The market is expected grow with the same trends during the forecast period. The major drivers supporting the growth of the market will be presence of huge diabetic patient population in Asia Pacific region like India and China. According to WHO (2014), 60% of the world’s total diabetic population lives in Asia region. Moreover, the global test strip market is driven by rising geriatric population, and rapid development in the test strips has driven the growth of the market. Moreover, changing lifestyle, and government initiatives for encouragement for the research & development has fuelled the market growth. On the other hand, availability of alternative methods for diagnosis like saliva collection devices has restrained the growth of global test strip market.

Global Test Strip Market - Competitive Analysis

The test strips are based on various technologies such as electrochemical and photometric. Majority of the test strips are based on electrochemical technology. The photometric technology market is expected to witness the highest growth. Roche Diagnostics, Lifescan, Inc., Abbott Laboratories, and Bayer are the leading players in the test strip market, by volume. These players possess state of art manufacturing facilities and strong sales and distribution network which have helped them to gain leadership position in the market. The other prominent players include Arkray Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Chiltern Medicare Ltd, Henry Schein, Lifeassay Diagnostics (Pty), Siemens Healthcare, Taidoc Technology Corporation, and Teco Diagnostics among others are some of the small players that accounts a reasonable amount of share in the test strip market.  

The global test strip market is highly fragmented with the presence of many local players and international players. As a result, local players are focus on cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through FDA approvals, collaborations to expand their overall market share. For instance, Abbot a leading player in the test strip market has received US Food and Drug Administration (FDA) clearance for its new product FreeStyle Lite blood glucose test strips that minimizes the interference during blood glucose testing, hence is fabricated for a better testing experience. This will help Abbott to create an impact on the patient pool and will help to increase its sales by volume.

Hoffmann-La Roche Ltd, Swiss multinational healthcare company focuses on the development and distribution of test strips. For this, in June 2017, Roche has acquired mySugr to form a leading open platform for digital diabetes management. Hence, the growing mergers and acquisitions, new product launches in the field of test strip has upsurged the growth of the market.

Hoffmann-La Roche Ltd (Switzerland), Siemens Ltd. (Germany), Abbott (US), B. Braun (Germany), LifeScan, Inc. (US), Chiltern MediCare Ltd. (US), Henry Schein, Inc. (US), Lifeassay Diagnostics (South Africa), Siemens Healthcare Private Limited (Germany), ARKRAY Inc. (US), Ascensia Diabetes Care Holdings AG. (Switzerland), TaiDoc Technology Corporation (Taiwan), Teco Diagnostics (US) are some of the prominent players at the forefront of competition in the Global Test Strip Market and are profiled in MRFR Analysis.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/test-strip-market-672